Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Ro-25-4020: mechanism underlying enhanced anticancer properties compared to 1,25(OH)2D3

July 2, 2002

Long-term results for Photofrin show potential efficacy in prevention of esophageal cancer

July 1, 2002

Antitumor compounds with affinity for Hsp90

July 1, 2002

New angiogenesis inhibitors in Boehringer Ingelheim pipeline

July 1, 2002

NDA filing completed for oxaliplatin in advanced colorectal cancer

July 1, 2002

Xyotax demonstrates ability to control disease in chemotherapy-resistant cancer patients

July 1, 2002

Corixa granted appeal for Bexxar

June 28, 2002

131I-TM-601 receives orphan drug status in U.S.

June 28, 2002

New MEK inhibitors in early development at AstraZeneca

June 28, 2002

Sigma-Tau patents antitumor and chemosensitizing compounds

June 28, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...